REQUEST A DEMO
Total
USD $0.00
Search more companies

Sasdi Medikament Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: SASDI Medikament Termelo, Szolgaltato es Kereskedelmi Kft. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Sasdi Medikament Kft. is a company based in Hungary, with its head office in Ujhartyan. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on April 23, 1998. 26 (2023) employees currently work for Sasdi Medikament Kft.. There was a net sales revenue increase of 46.32% reported in Sasdi Medikament Kft.’s latest financial highlights for 2022. A growth of 13.39% was recorded in its total assets. In 2022, Sasdi Medikament Kft.’s net profit margin increased by 17.18%.

Headquarters
Fo utca 16.
Ujhartyan; Pest; Postal Code: 2367

Contact Details: Purchase the Sasdi Medikament Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Sasdi Medikament Kft. report to view the information.
Outstanding Shares:
Purchase the Sasdi Medikament Kft. report to view the information.
Registered Capital:
Purchase the Sasdi Medikament Kft. report to view the information.
Financial Auditors:
Purchase the Sasdi Medikament Kft. report to view the information.
Incorporation Date:
April 23, 1998
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Sasdi Medikament Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
46.32%
Total operating revenue
44.89%
Operating profit (EBIT)
197.45%
EBITDA
119.12%
Net Profit (Loss) for the Period
197%
Total assets
13.39%
Total equity
20.04%
Operating Profit Margin (ROS)
18.26%
Net Profit Margin
17.18%
Return on Equity (ROE)
14.1%
Quick Ratio
-0.33%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?